Days
Hours
Minutes
Seconds
-40%
on all subscriptions*
Last days
Enjoy this offer
* See conditions under "Our services"

Valuation: Stereotaxis Inc

Market Cap 180M 155M 143M 134M 251M 17B 254M 1.69B 659M 8.32B 675M 661M 28.8B P/E Ratio 2026 *
-9.2x
P/E Ratio 2027 * -12.3x
Enterprise Value 180M 155M 143M 134M 251M 17B 254M 1.69B 659M 8.32B 675M 661M 28.8B EV / Sales 2026 *
4.56x
EV / Sales 2027 * 3.38x
Free-Float
84.63%
Yield 2026 *
-
Yield 2027 * -
Manager TitleAgeSince
Chief Executive Officer 39 2017-02-02
Director of Finance/CFO 57 2019-09-30
Chief Operating Officer - -
Director TitleAgeSince
Director/Board Member 79 2005-01-31
Chairman 39 2017-02-02
Director/Board Member 71 2016-09-28
Change 5-day change 1-year change 3-year change Capi.($)
+36.13%-2.84% - - 180M
+1.45%+1.35%+17.51%-11.05% 174B
+1.11%-0.52%-19.77%+26.86% 146B
+0.81%-1.12%-9.76%-25.47% 127B
+0.05%-3.55%-53.72%-12.98% 69.72B
+0.60%-0.19%+14.52%-6.14% 49.01B
+0.95%+1.72%-24.07%-33.43% 44.74B
+0.79%-1.18%+10.17%+8.16% 36.67B
+0.57%-1.44%+2.97%+33.58% 34.91B
+0.27%+1.02%-10.33%-17.41% 29.65B
Average -0.14%-1.85%-8.05%-4.21% 79.13B
Weighted average by Cap. +0.86%-1.87%-7.03%-4.23%

Financials

2026 *2027 *
Net sales 39.4M 33.96M 31.25M 29.32M 55.07M 3.72B 55.62M 369M 144M 1.82B 148M 145M 6.31B 53.28M 45.92M 42.26M 39.64M 74.47M 5.03B 75.21M 500M 195M 2.47B 200M 196M 8.53B
Net income -19.4M -16.72M -15.39M -14.44M -27.12M -1.83B -27.39M -182M -71.06M -898M -72.8M -71.26M -3.11B -13.62M -11.74M -10.81M -10.14M -19.05M -1.29B -19.24M -128M -49.91M -631M -51.13M -50.05M -2.18B
Net Debt - -
Logo Stereotaxis Inc
Stereotaxis, Inc. designs, manufactures, and markets robotic systems, instruments, and information systems for the interventional laboratory. Its proprietary robotic technology, Robotic Magnetic Navigation (RMN), fundamentally transforms endovascular interventions using precise computer-controlled magnetic fields to directly control the tip of flexible interventional catheters or devices. The Company’s primary products include the Genesis RMN System, the Odyssey Solution, and other related devices. Through its strategic relationships with fluoroscopy system manufacturers, providers of catheters and electrophysiology mapping systems, and other parties, the Company offers its customers x-ray systems and other accessory devices. The Genesis RMN System is designed to enable physicians to complete more complex interventional procedures by providing image-guided delivery of catheters through the blood vessels and chambers of the heart to treatment sites.
Employees
-
Trader
Investor
-
Global
-
Quality
-
ESG MSCI
-
- 40% : Our Best Subscriber-Only Tools to Spot Tomorrow’s Top Investments!
d
:
:
SEIZE THE OFFER!